Less Commonly Known Bulimia Side Effects [BEST]

A sore throat, stomach pain, or both may be the first obvious physical side effects of bulimia. As the disorder progresses, chronic self-induced vomiting can cause a variety of symptoms in the digestive tract, beginning at the mouth. Over time, the high acid content of vomit can damage teeth and cause enamel erosion, tooth sensitivity, and gum disease. Puffy cheeks or jaws may be noticed secondary to swollen salivary glands.

Less Commonly Known Bulimia Side Effects

Download File: https://www.google.com/url?q=https%3A%2F%2Furloso.com%2F2tPWCC&sa=D&sntz=1&usg=AOvVaw3qNqBXNN5hz8FaYvTbgXk9

Bulimia nervosa is an eating disorder with symptoms that commonly include repeated episodes of extreme overeating followed by self-induced vomiting, lack of control over this binge-purge cycle, and a poor or unrealistic body image. You may already know that bulimia can lead to serious health problems such as dehydration, inflammation of the esophagus, tooth decay, electrolyte imbalances and potentially fatal changes in normal heart function. However, the disorder can also produce a range of less well-known side effects.

Changes in menstruation are a well-known potential effect of another eating disorder, anorexia nervosa. However, they also frequently occur as side effects of bulimia. As many as half of all teenagers and women affected by the disorder will stop menstruating altogether for extended periods of time. Substantial numbers will also menstruate intermittently or experience a reduced menstrual flow.

In a small number of cases, bulimia side effects can also include a condition called aspiration pneumonia. This condition occurs when an infection or inflammation affects the passageway leading to your lungs or your lungs themselves. In a person with bulimia, the typical cause of aspiration pneumonia is accidental inhalation of vomited food during a purging episode. A very small number of individuals dealing with the eating disorder develop another chest-related condition called pneumomediastinum, which occurs when air abnormally fills the mediastinum, a cavity located between your lungs.

In controlled trials of patients ages 18 to 55 years, 5.1% (19/373) of VYVANSE-treated patients discontinued due to adverse reactions compared to 2.4% (9/372) of placebo-treated patients. No single adverse reaction led to discontinuation in 1% or more of VYVANSE-treated patients. Less commonly reported adverse reactions (less than 1% or less than twice rate of placebo) included increased heart rate, headache, abdominal pain upper, dyspnea, rash, insomnia, irritability, feeling jittery and anxiety.